Healthcare -
Biotechnology - NASDAQ - US
$ 8.155
-4.51 %
$ 1.7 B
Market Cap
-18.97
P/E
BCRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BCRX - BioCryst Pharmaceuticals, Inc.
32.5 M
LAST VALUE
-69.95%
2 YEAR CAGR
-12.27%
5 YEAR CAGR
0.71%
10 YEAR CAGR